Experimental eye drops for GVHD dry eye show early promise but study halted
Disease control
Terminated
This study tested a new eye drop (rhPRG4) in 3 adults with moderate to severe dry eye from chronic graft-versus-host disease (GVHD), a complication of bone marrow transplants. The goal was to see if the drops safely improve dryness and eye surface damage. The trial was terminated…
Phase: PHASE1, PHASE2 • Sponsor: Lubris Bio Pty Ltd • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC